UK approves oral semaglutide tablet for weight management
Medscape reports the tablet formulation of Novo Nordisk's semaglutide has cleared UK regulators for weight loss.
DO
By Daniel Okafor · Regulatory Correspondent
Jun 12 03:00 ETSource: Medscape
The wire
- 01UK regulators have authorised a semaglutide tablet for weight loss, adding an oral option alongside injectable semaglutide.
- 02An oral incretin route matters for prescribers and pharmacies handling needle-averse patients and cold-chain constraints.
- 03Details on pricing, NHS access and rollout timing were not given in the report.
From the source
Read at medscape.comSemaglutide Tablet Wins UK Approval for Weight Loss